The global market for Drug Eluting Balloons (DEBs) was estimated at US$1.4 Billion in 2023 and is projected to reach US$3 Billion by 2030, growing at a CAGR of 9.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Drug Eluting Balloons (DEBs) Market]( "Drug Eluting Balloons (DEBs) Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Peripheral Drug Eluting Balloons segment, which is expected to reach US$1.7 Billion by 2030 with a CAGR of 8.1%. The Coronary Drug Eluting Balloons segment is also set to grow at 12.5% CAGR for the next 8-year period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $433.5 Million in 2023, and China, forecasted to grow at an impressive 9.5% CAGR to reach $534.7 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Drug Eluting Balloons (DEBs) Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Drug Eluting Balloons (DEBs) Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Drug Eluting Balloons (DEBs) Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Acrostak Int. Distr. Sarl, B. Braun Melsungen AG, BARD, A Becton, Dickinson Company, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 42 Featured):
- Acrostak Int. Distr. Sarl
- B. Braun Melsungen AG
- BARD, A Becton, Dickinson Company
- Cardionovum GmbH
- Cook Medical, Inc.
- Eurocor GmbH
- Medtronic PLC
- Spectranetics Corporation
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- Drug Eluting Balloons (DEBs) - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
- Global Economic Update
3. MARKET TRENDS & DRIVERS
- Growing Incidence of Cardiovascular Diseases Drives Demand for Drug Eluting Balloons (DEBs)
- Increasing Focus on Minimally Invasive Procedures Strengthens Business Case for Drug Eluting Balloons
- Expansion of Peripheral Artery Disease (PAD) Treatment Spurs Demand for DEBs in Vascular Interventions
- Technological Innovations in Biodegradable Polymers Set the Stage for Market Growth in Drug Eluting Balloons
- Rising Adoption of DEBs in Coronary Artery Disease (CAD) Treatment Expands Market Opportunities
- Increasing Use of DEBs in Renal and Carotid Artery Interventions Expands Market Opportunities
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 2: World Historic Review for Drug Eluting Balloons (DEBs) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 3: World 16-Year Perspective for Drug Eluting Balloons (DEBs) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
- TABLE 4: World Recent Past, Current & Future Analysis for Cath Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 5: World Historic Review for Cath Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 6: World 16-Year Perspective for Cath Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 7: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 8: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 9: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 10: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 11: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 12: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 13: World Drug Eluting Balloons (DEBs) Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Peripheral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 15: World Historic Review for Peripheral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 16: World 16-Year Perspective for Peripheral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Coronary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 18: World Historic Review for Coronary by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 19: World 16-Year Perspective for Coronary by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
UNITED STATES
- Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 20: USA Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 21: USA Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 22: USA 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
- TABLE 23: USA Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 24: USA Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 25: USA 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
CANADA
- TABLE 26: Canada Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 27: Canada Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 28: Canada 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
- TABLE 29: Canada Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 30: Canada Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 31: Canada 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
JAPAN
- Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 32: Japan Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 33: Japan Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 34: Japan 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
- TABLE 35: Japan Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 36: Japan Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 37: Japan 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
CHINA
- Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 38: China Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 39: China Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 40: China 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
- TABLE 41: China Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 42: China Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 43: China 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
EUROPE
- Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 44: Europe Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
- TABLE 45: Europe Historic Review for Drug Eluting Balloons (DEBs) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 46: Europe 16-Year Perspective for Drug Eluting Balloons (DEBs) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 47: Europe Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 48: Europe Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 49: Europe 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
- TABLE 50: Europe Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 51: Europe Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 52: Europe 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
FRANCE
- Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 53: France Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 54: France Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 55: France 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
- TABLE 56: France Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 57: France Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 58: France 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
GERMANY
- Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 59: Germany Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 60: Germany Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 61: Germany 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
- TABLE 62: Germany Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 63: Germany Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 64: Germany 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
ITALY
- TABLE 65: Italy Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 66: Italy Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 67: Italy 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
- TABLE 68: Italy Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 69: Italy Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 70: Italy 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 71: UK Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 72: UK Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 73: UK 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
- TABLE 74: UK Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 75: UK Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 76: UK 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
REST OF EUROPE
- TABLE 77: Rest of Europe Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 78: Rest of Europe Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 79: Rest of Europe 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
- TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 81: Rest of Europe Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 82: Rest of Europe 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Drug Eluting Balloons (DEBs) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 83: Asia-Pacific Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 84: Asia-Pacific Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 85: Asia-Pacific 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
- TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 87: Asia-Pacific Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 88: Asia-Pacific 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
REST OF WORLD
- TABLE 89: Rest of World Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 90: Rest of World Historic Review for Drug Eluting Balloons (DEBs) by Product - Peripheral and Coronary Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 91: Rest of World 16-Year Perspective for Drug Eluting Balloons (DEBs) by Product - Percentage Breakdown of Value Sales for Peripheral and Coronary for the Years 2014, 2024 & 2030
- TABLE 92: Rest of World Recent Past, Current & Future Analysis for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
- TABLE 93: Rest of World Historic Review for Drug Eluting Balloons (DEBs) by End-Use - Hospitals, Cath Labs and Ambulatory Surgery Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
- TABLE 94: Rest of World 16-Year Perspective for Drug Eluting Balloons (DEBs) by End-Use - Percentage Breakdown of Value Sales for Hospitals, Cath Labs and Ambulatory Surgery Centers for the Years 2014, 2024 & 2030
Companies Mentioned
- Acrostak Int. Distr. Sarl
- B. Braun Melsungen AG
- BARD, A Becton, Dickinson Company
- Cardionovum GmbH
- Cook Medical, Inc.
- Eurocor GmbH
- Medtronic PLC
- Spectranetics Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 194 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 1.4 Billion |
| Forecasted Market Value ( USD | $ 3 Billion |
| Compound Annual Growth Rate | 9.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 8 |
